Kolonko, A.; Bzoma, B.; Giza, P.; Styrc, B.; Sobolewski, M.; Chudek, J.; Dębska-Ślizień, A.; Więcek, A.
The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients. Medicina 2018, 54, 66.
https://doi.org/10.3390/medicina54050066
AMA Style
Kolonko A, Bzoma B, Giza P, Styrc B, Sobolewski M, Chudek J, Dębska-Ślizień A, Więcek A.
The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients. Medicina. 2018; 54(5):66.
https://doi.org/10.3390/medicina54050066
Chicago/Turabian Style
Kolonko, Aureliusz, Beata Bzoma, Piotr Giza, Beata Styrc, Michał Sobolewski, Jerzy Chudek, Alicja Dębska-Ślizień, and Andrzej Więcek.
2018. "The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients" Medicina 54, no. 5: 66.
https://doi.org/10.3390/medicina54050066
APA Style
Kolonko, A., Bzoma, B., Giza, P., Styrc, B., Sobolewski, M., Chudek, J., Dębska-Ślizień, A., & Więcek, A.
(2018). The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients. Medicina, 54(5), 66.
https://doi.org/10.3390/medicina54050066